Cargando…
P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431345/ http://dx.doi.org/10.1097/01.HS9.0000847600.12970.7d |
| _version_ | 1784780029191782400 |
|---|---|
| author | Borchmann, P. Lohneis, A. Gödel, P. Balke-Want, H. Schmid, C. Ayuk, F. Holtkamp, S. Hanssens, L. Zadoyan, G. Friedrichs, B. Assenmacher, M. Bürger, I. Schneider, D. Overstijns, T. Scheid, C. Holtick, U. Miltenyi, S. Hallek, M. |
| author_facet | Borchmann, P. Lohneis, A. Gödel, P. Balke-Want, H. Schmid, C. Ayuk, F. Holtkamp, S. Hanssens, L. Zadoyan, G. Friedrichs, B. Assenmacher, M. Bürger, I. Schneider, D. Overstijns, T. Scheid, C. Holtick, U. Miltenyi, S. Hallek, M. |
| author_sort | Borchmann, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94313452022-08-31 P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT Borchmann, P. Lohneis, A. Gödel, P. Balke-Want, H. Schmid, C. Ayuk, F. Holtkamp, S. Hanssens, L. Zadoyan, G. Friedrichs, B. Assenmacher, M. Bürger, I. Schneider, D. Overstijns, T. Scheid, C. Holtick, U. Miltenyi, S. Hallek, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431345/ http://dx.doi.org/10.1097/01.HS9.0000847600.12970.7d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Borchmann, P. Lohneis, A. Gödel, P. Balke-Want, H. Schmid, C. Ayuk, F. Holtkamp, S. Hanssens, L. Zadoyan, G. Friedrichs, B. Assenmacher, M. Bürger, I. Schneider, D. Overstijns, T. Scheid, C. Holtick, U. Miltenyi, S. Hallek, M. P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT |
| title | P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT |
| title_full | P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT |
| title_fullStr | P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT |
| title_full_unstemmed | P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT |
| title_short | P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT |
| title_sort | p1184: phase i trial of mb-cart2019.1 in patientes with relapsed or refratory b-cell non-hodgkin lymphoma: 2 year follow-up report |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431345/ http://dx.doi.org/10.1097/01.HS9.0000847600.12970.7d |
| work_keys_str_mv | AT borchmannp p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT lohneisa p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT godelp p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT balkewanth p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT schmidc p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT ayukf p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT holtkamps p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT hanssensl p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT zadoyang p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT friedrichsb p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT assenmacherm p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT burgeri p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT schneiderd p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT overstijnst p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT scheidc p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT holticku p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT miltenyis p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport AT hallekm p1184phaseitrialofmbcart20191inpatienteswithrelapsedorrefratorybcellnonhodgkinlymphoma2yearfollowupreport |